Resources
| Name | Description | Data sources | Responsible organisation(s) | Measure methodology last updated |
|---|---|---|---|---|
| Residents dispensed vitamin D in aged residential care (ARC) | Percentage of ARC residents who were dispensed vitamin D. Internationally, vitamin D is widely recommended for reducing falls and fall-related injuries in older people. Vitamin D supplements are thought to prevent falls by improving muscle strength and psychomotor performance in older people at risk of vitamin D deficiency. Nationally, there has been a long-established programme to increase the uptake of prescribed vitamin D supplements to older people in ARC. | Pharmaceutical Collection (PHARMS), Client claims processing system – Manatū Hauora | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Home to home within 120 days | This is a measure of the percentage of hip fracture patients living in a private residence before admission who return to live in a private residence within 120 days of admission. | Australian & New Zealand Hip Fracture Registry | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Survival at 120 days | This is a measure of the percentage of hip fracture patients who are alive at 120 days after admission. | Australian & New Zealand Hip Fracture Registry | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Walking ability at 120 days | This is a measure of the percentage of hip fracture patients who returned to their pre-fracture mobility at 120 days after admission. | Australian & New Zealand Hip Fracture Registry | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Bone protection medication within 120 days | This is a measure of the percentage of hip fracture patients who were given bone protection medication within 120 days after admission. | Australian & New Zealand Hip Fracture Registry | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Bisphosphonates coverage | This is a measure of the percentage of people in the population covered by bisphosphonates. Bisphosphonates are a class of drugs that reduce bone density loss. Bisphosphonates should be considered for people who have fallen and sustained a fracture to reduce their future risk of fracture. | Pharmaceutical Collection (PHARMS), National Population Projection - Stats NZ | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Bisphosphonates new starts | This is a measure of people newly started on bisphosphonates as a proportion of ACC fracture claims. Bisphosphonates are a class of drugs that reduce bone density loss. Bisphosphonates should be considered for people who have fallen and sustained a fracture, to reduce their future risk of fracture. ‘New starts’ identifies people who were not covered by bisphosphonates in the previous 2 years. | Pharmaceutical Collection (PHARMS), Claims data – ACC | Health Quality & Safety Commission | Te Tāhū Hauora |